Literature DB >> 1550670

The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes.

M M Daston1, H Scrable, M Nordlund, A K Sturbaum, L M Nissen, N Ratner.   

Abstract

von Recklinghausen's neurofibromatosis (NF1) is a common inherited human disease. The events leading to patient symptoms from inheritance of a defective NF1 gene are unknown. Since knowledge of the distribution of the normal NF1 gene product should improve understanding of the pathogenesis of the disease, we raised antibodies against peptides coded by portions of the recently cloned human NF1 cDNA. These antibodies specifically recognize a 220 kd protein (neurofibromin) in both human and rat spinal cord. Neurofibromin is most abundant in the nervous system. Immunostaining of tissue sections indicates that neurons, oligodendrocytes, and nonmyelinating Schwann cells contain neurofibromin while astrocytes and myelinating Schwann cells do not. These results suggest a function for neurofibromin in the normal nervous system. Some NF1 disease manifestations, such as Schwann cell tumors and learning disabilities, may result from abnormalities in the cells that express neurofibromin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1550670     DOI: 10.1016/0896-6273(92)90270-n

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  64 in total

1.  Bipartite interaction between neurofibromatosis type I protein (neurofibromin) and syndecan transmembrane heparan sulfate proteoglycans.

Authors:  Y P Hsueh; A M Roberts; M Volta; M Sheng; R G Roberts
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

Review 2.  A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.

Authors:  Nancy Ratner; Shyra J Miller
Journal:  Nat Rev Cancer       Date:  2015-04-16       Impact factor: 60.716

3.  Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I.

Authors:  Weixi Wang; Jeffry S Nyman; Koichiro Ono; David A Stevenson; Xiangli Yang; Florent Elefteriou
Journal:  Hum Mol Genet       Date:  2011-07-14       Impact factor: 6.150

4.  Neurofibromatosis: chronological history and current issues.

Authors:  João Roberto Antônio; Eny Maria Goloni-Bertollo; Lívia Arroyo Trídico
Journal:  An Bras Dermatol       Date:  2013 May-Jun       Impact factor: 1.896

Review 5.  Spinal deformity in neurofibromatosis type-1: diagnosis and treatment.

Authors:  Athanasios I Tsirikos; Asif Saifuddin; M Hilali Noordeen
Journal:  Eur Spine J       Date:  2005-02-15       Impact factor: 3.134

Review 6.  Small G protein signaling in neuronal plasticity and memory formation: the specific role of ras family proteins.

Authors:  Xiaojing Ye; Thomas J Carew
Journal:  Neuron       Date:  2010-11-04       Impact factor: 17.173

7.  Aberrant Ras regulation and reduced p190 tyrosine phosphorylation in cells lacking p120-Gap.

Authors:  P van der Geer; M Henkemeyer; T Jacks; T Pawson
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

8.  Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells.

Authors:  D Muir; D Neubauer; I T Lim; A T Yachnis; M R Wallace
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

9.  Neurofibromin C terminus-specific antibody (clone NFC) is a valuable tool for the identification of NF1-inactivated GISTs.

Authors:  Sabrina Rossi; Daniela Gasparotto; Matilde Cacciatore; Marta Sbaraglia; Alessia Mondello; Maurizio Polano; Alessandra Mandolesi; Alessandro Gronchi; David E Reuss; Andreas von Deimling; Roberta Maestro; Angelo Paolo Dei Tos
Journal:  Mod Pathol       Date:  2017-09-01       Impact factor: 7.842

Review 10.  Molecular genetics of neurofibromatosis type 1 (NF1).

Authors:  M H Shen; P S Harper; M Upadhyaya
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.